SCHEMBL1429918

SCHEMBL1429918

CC#CC[C@H](NC(=O)OC(C)(C)C)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CTSK P43235 9/20 0.61
CTSS P25774 10/20 0.49
CTSL P07711 2/20 0.47
CTSB P07858 2/20 0.47
PPARA Q07869 6/20 0.44
PPARG P37231 5/20 0.44
ACE P12821 1/20 0.43
PPARD Q03181 2/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2399357 1.00 CTSK (0.61) CTSKCTSSCTSLCTSBPPARA
SCHEMBL1429799 1.00 CTSK (0.61) CTSKCTSSCTSLCTSBPPARA
SCHEMBL7788744 0.87 CTSK (0.55) CTSKCTSSCTSLCTSBPPARA
SCHEMBL7788178 0.87 CTSK (0.55) CTSKCTSSCTSLCTSBPPARA
SCHEMBL28613325 0.86 CTSS (0.48) CTSKCTSSCTSLCTSBPPARA
SCHEMBL28613327 0.86 CTSS (0.48) CTSKCTSSCTSLCTSBPPARA
SCHEMBL8139777 0.84 CTSK (0.58) CTSKCTSSCTSLCTSBCA1
SCHEMBL17533115 0.83 CTSS (0.46) CTSKCTSSCTSLCTSBPPARA
SCHEMBL4657580 0.83 CTSK (0.57) CTSKCTSSCTSLCTSBCA1
SCHEMBL29651451 0.83 CTSS (0.64) CTSKCTSSCTSLCTSBPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112778162-A Preparation method of chiral beta- (Boc-amino) -5-hexynoic acid 上海海皋科技有限公司 2021-05-11 CN claimed
CN-112778162-B Preparation method of chiral beta- (Boc-amino) -5-hexynoic acid 上海海皋科技有限公司 2023-06-16 CN disclosed
CN-112778162-A Preparation method of chiral beta- (Boc-amino) -5-hexynoic acid 上海海皋科技有限公司 2021-05-11 CN disclosed
EP-2300452-A1 5-Ý5-Ý2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-2-METHYLPROPANOYLMETHYLAMINO¨-4-(4-FLUORO-2-METHYLPHENYL)¨-2-PYRIDINYL-2-ALKYL-PROLINAMIDE AS NK1 RECEPTOR ANTAGONISTS Glaxo Wellcome Manufacturing Pte Ltd (SG) 2011-03-30 EP disclosed